Related Experiment Video
Updated: Jun 27, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF
Catherine Paradis-Bleau1, Adrian Lloyd, François Sanschagrin
1Département de Biologie Médicale, Université Laval, Sainte-Foy, Québec G1K 7P4, Canada. Catherine_Paradis-Bleau@hms.harvard.edu
Background:
To develop antibacterial agents having novel modes of action against bacterial cell wall biosynthesis, we targeted the essential MurF enzyme of the antibiotic resistant pathogen Pseudomonas aeruginosa. MurF catalyzes the formation of a peptide bond between D-Alanyl-D-Alanine (D-Ala-D-Ala) and the cell wall precursor uridine 5'-diphosphoryl N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid (UDP-MurNAc-Ala-Glu-meso-A2pm) with the concomitant hydrolysis of ATP to ADP and inorganic phosphate, yielding UDP-N-acetylmuramyl-pentapeptide. As MurF acts on a dipeptide, we exploited a phage display approach to identify peptide ligands having high binding affinities for the enzyme.
Results:
Screening of a phage display 12-mer library using purified P. aeruginosa MurF yielded to the identification of the MurFp1 peptide. The MurF substrate UDP-MurNAc-Ala-Glumeso-A2pm was synthesized and used to develop a sensitive spectrophotometric assay to quantify MurF kinetics and inhibition. MurFp1 acted as a weak, time-dependent inhibitor of MurF activity but was a potent inhibitor when MurF was pre-incubated with UDP-MurNAc-Ala-Glu-meso-A2pm or ATP. In contrast, adding the substrate D-Ala-D-Ala during the pre-incubation nullified the inhibition. The IC50 value of MurFp1 was evaluated at 250 microM, and the Ki was established at 420 microM with respect to the mixed type of inhibition against D-Ala-D-Ala.
Conclusion:
MurFp1 exerts its inhibitory action by interfering with the utilization of D-Ala-D-Ala by the MurF amide ligase enzyme. We propose that MurFp1 exploits UDP-MurNAc-Ala-Glu-meso-A2pm-induced structural changes for better interaction with the enzyme. We present the first peptide inhibitor of MurF, an enzyme that should be exploited as a target for antimicrobial drug development.
Insights
We identified MurFp1, a novel peptide inhibitor targeting the MurF enzyme in Pseudomonas aeruginosa. This peptide interferes with D-Ala-D-Ala utilization, offering a new strategy against antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Targeting essential enzymes in bacterial cell wall biosynthesis is crucial for developing novel antibacterial agents.
- Pseudomonas aeruginosa, an antibiotic-resistant pathogen, possesses the essential MurF enzyme involved in cell wall precursor peptide formation.
- MurF catalyzes peptide bond formation using UDP-MurNAc-Ala-Glu-meso-A2pm and D-Ala-D-Ala, with ATP hydrolysis.
Purpose of the Study:
- To develop novel antibacterial agents by targeting the MurF enzyme.
- To identify peptide ligands with high binding affinity for MurF using a phage display approach.
Main Methods:
- Screening of a phage display 12-mer library against purified Pseudomonas aeruginosa MurF.
- Synthesis of the MurF substrate UDP-MurNAc-Ala-Glu-meso-A2pm.
- Development of a spectrophotometric assay to quantify MurF kinetics and inhibition.
- Evaluation of MurFp1 inhibition kinetics and IC50/Ki values.
Main Results:
- Identification of the MurFp1 peptide through phage display screening.
- MurFp1 demonstrated time-dependent inhibition, becoming potent upon pre-incubation with UDP-MurNAc-Ala-Glu-meso-A2pm or ATP.
- Inhibition was nullified by D-Ala-D-Ala during pre-incubation, indicating interference with D-Ala-D-Ala utilization.
- MurFp1 exhibited an IC50 of 250 microM and a Ki of 420 microM (mixed type inhibition against D-Ala-D-Ala).
Conclusions:
- MurFp1 is the first identified peptide inhibitor of the MurF enzyme.
- The inhibitory mechanism involves interference with D-Ala-D-Ala utilization by MurF.
- MurFp1 likely exploits UDP-MurNAc-Ala-Glu-meso-A2pm-induced structural changes for enhanced enzyme interaction.
- MurF represents a promising target for the development of new antimicrobial drugs.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Archaeal Cell Wall
Inhibitors Of Virion Release
Bacterial Cell Wall
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis

